Developer docs
API playgroundTry for free, no card

Search company profiles

nyra health

Full company profile

uuid00029vm

Namestring
nyra health
Legal namestring
nyra health GmbH
Websiteurl
nyra.health
Company typeenum
Private
Founded yearint
2018
Descriptiontext

nyra health is a Vienna-based HealthTech company developing an AI-powered digital neurotherapy platform for patients recovering from neurological conditions such as stroke, dementia, Parkinson's disease, traumatic brain injury, and multiple sclerosis. Founded in 2018 by Dr. Philipp Schöllauf, Moritz Schöllauf, and Mario Zusag, the company addresses the post-discharge continuity gap in neurological rehabilitation through its CE-certified myReha mobile therapy app, which delivers personalized speech, language, cognitive, and motor exercises and is integrated into clinical workflows via the nyra insights web platform and the AI-driven nyra Content Studio tooling for therapists. The underlying technology stack combines Whisper-based automatic speech recognition, NLP pipelines for aphasia and dementia classification, MMSE score prediction, and multimodal AI models developed in collaboration with US universities. The company's US-market sub-brand is 'nyra therapy.'

nyra health operates a three-stream revenue model: B2C monthly and annual subscriptions for individual patients (preceded by a 7-day free trial), B2B licensing agreements with rehabilitation clinics and therapy practices, and insurance-covered sessions through partnerships with 28 health insurance providers across Germany, Austria, and Switzerland, including TK, AOK, Signal Iduna, and Barmenia. The platform is deployed in over 100 rehabilitation clinics (including Schmieder, SRH, Asklepios, and Mediclin) and has been used by 50,000+ patients across 65,000+ therapy tasks. nyra health maintains certifications including ISO 13485, ISO 27001/27017/27018, SOC 1-3, CE marking, and GDPR compliance.

The company has raised a total of approximately €24.5M, including a €4.5M seed round in 2023 and a €20M Series A in February 2026 led by Armira Growth with participation from Wellington Partners, Crane Venture Partners, and EVER Pharma. Use of proceeds is directed at DACH expansion, US market entry through the 'nyra therapy' sub-brand, and further development of multimodal AI capabilities, including a €4.2M research initiative with US universities. The company employs 11-50 people and is registered as nyra health GmbH in Vienna, Austria.

Short descriptiontext

nyra health is a Vienna-based HealthTech company building an AI-powered digital neurotherapy platform for stroke, dementia, Parkinson's, and brain injury patients, delivering personalized speech, cognitive, and motor therapy through its CE-certified myReha app and nyra insights clinical platform across the DACH region.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
11–50
akta.pro rankint
HeadquartersVienna, Austria
HQ citystring
Vienna
HQ countrystring
Austria
HQ regionstring
Europe
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
digital neurotherapy, AI neurorehabilitation, speech therapy software, cognitive rehabilitation platform, telemedicine stroke recovery
Industry4 codes
1Behavioral Health & Neurocognitive Therapeutics (Digital)
CodeHLACANAIPrimaryYes
2Remote Therapeutic Monitoring (RTM) & Digital Rehabilitation Platforms
CodeHLALABAKPrimaryNo
3Digital Rehabilitation & Physical Therapy Therapeutics
CodeHLACANAJPrimaryNo
4Cognitive-Communication & Memory Rehab Therapy In-Home
CodeHSABADALPrimaryNo
NAICS code2 codes
  • Offices of Physical, Occupational and Speech Therapists, and Audiologists62134
  • Offices of Physical, Occupational and Speech Therapists, and Audiologists621340
SIC code3 codes
  • Services-Prepackaged Software7372
  • Services-Home Health Care Services8082
  • Services-Health Services8000
Product category
Digital Neurorehabilitation Software
Social media profiles1 record
GTM motion2 records

Each record includes

Type, Description, Source

Revenue model3 records
1Patient Subscriptions (B2C)
TypeSubscription Recurring
Description

Monthly and annual subscription plans for patients accessing the digital neurotherapy platform. Premium tiers offer enhanced features and extended therapy programs. A 7-day free trial enables user acquisition before conversion to paid subscriptions.

2Clinic/Healthcare Provider Licensing
TypeSubscription Recurring
Description

B2B licensing agreements with rehabilitation clinics, therapy practices, and healthcare systems for institutional access to the nyra health platform. Clinics license the platform for use with their patient populations.

3Insurance Reimbursement Partnerships
TypeSubscription Recurring
Description

Partnerships with health insurance companies enable coverage of nyra health therapy programs for insured members, creating a reimbursement pathway similar to traditional therapy sessions.

Marketing channels5 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels4 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Personnel, Technology or R&D, Operations, Marketing or Sales, Infrastructure
Pricing details3 tiers
1Standard Monthly Subscription
ModelSubscriptionBilling cadenceMonthly
Notes

Monthly subscription for individual patients with access to core neurotherapy features and personalized therapy programs

2Premium Annual Subscription
ModelSubscriptionBilling cadenceAnnual
Notes

Annual subscription option with discounted rate compared to monthly billing, offering full access to premium features

3Insurance-Covered Sessions
ModelUsage-basedBilling cadencePay-as-you-go
Notes

Insurance-covered sessions through partnerships with TK, AOK, and other major insurers, reducing out-of-pocket costs for insured patients

GTM typeB2B and B2C
B2B and B2C
Offering typeSoftware
Software
Brand1 of 3 records shown
1myReha
Description

AI-powered therapy app for neurological disorders covering speech, language, and cognitive therapy. CE-certified medical device deployed in rehabilitation clinics.

nyra.health
+2 more records
Core offering1 text field

nyra health sells a modular AI-powered digital neurotherapy ecosystem consisting of the myReha CE-certified mobile therapy app (speech, language, and cognitive rehabilitation for stroke, dementia, Parkinson's, TBI, and MS patients), the nyra insights web platform for clinician patient management and telemedical monitoring, and the nyra Content Studio AI tool for therapists to generate personalized therapy materials. The platform supports care from inpatient clinics to at-home therapy and is distributed through app stores, clinic licensing, and insurance reimbursement across the DACH region with US expansion underway.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 4 values shown
  • 50,000+ patients have used the platform for neurological rehabilitation
+3 more records
Product overview1 text field

nyra health offers a modular digital neurotherapy ecosystem consisting of three interconnected products: myReha (core mobile therapy app for patients), nyra insights (web-based clinical management platform), and nyra Content Studio (AI-powered content generation tool). The system provides seamless care from clinic to home, covering speech therapy, cognitive rehabilitation, and occupational therapy through over 65,000 interactive tasks. The platform operates across Germany, Austria, and Switzerland with reimbursement agreements covering 40 million insured individuals, while nyra therapy serves as the US-market sub-brand for the company's neurorehabilitation solutions.

Product and service4 records
1myReha
CategoryPatient-facing mobile therapy application
Description

CE-certified AI-powered mobile therapy application for smartphone and tablet providing personalized speech, language, and cognitive rehabilitation exercises for patients with neurological conditions including stroke, dementia, Parkinson's, traumatic brain injury, Long COVID, and multiple sclerosis. Targets individual patients for at-home therapy and is also deployed in clinical settings.

2nyra insights
CategoryClinician-facing web platform
Description

Web-based therapy platform for healthcare professionals enabling telemedical care, therapy documentation, patient management, and real-time monitoring of patient progress across clinics and practices. Targets clinicians and therapy teams as the institutional counterpart to the myReha patient app.

3nyra Content Studio
CategoryAI-powered therapy content generation tool
Description

AI-powered therapy content creation tool enabling therapists to generate personalized therapy materials in seconds using conversational AI. Designed for speech therapy, occupational therapy, and neuropsychology practices.

4nyra therapy
CategoryUS-market neurorehabilitation sub-brand
Description

US-market sub-brand of nyra health's neuro-rehabilitation platform enabling transition from inpatient care to home-based therapy, covering stroke, dementia, Parkinson's disease, Long COVID, traumatic brain injury, and multiple sclerosis for American patients and providers.

Scale indicator5 records

Each record includes

Type, Value, Description, Source

Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight5 records

Each record includes

Type, Description

Market position
Competitive moat5 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights6 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers4 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment3 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile3 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

AI capability8 records

Each record includes

Type, Description, Source

AI maturity
App detail

Has app

Feature3 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles3 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
Compliance9 records

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds3 records

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors6 records

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

nyra health

Digital Neurorehabilitation Softwarenyra.health

nyra health is a Vienna-based HealthTech company building an AI-powered digital neurotherapy platform for stroke, dementia, Parkinson's, and brain injury patients, delivering personalized speech, cognitive, and motor therapy through its CE-certified myReha app and nyra insights clinical platform across the DACH region.

What nyra health does

nyra health is a Vienna-based HealthTech company developing an AI-powered digital neurotherapy platform for patients recovering from neurological conditions such as stroke, dementia, Parkinson's disease, traumatic brain injury, and multiple sclerosis. Founded in 2018 by Dr. Philipp Schöllauf, Moritz Schöllauf, and Mario Zusag, the company addresses the post-discharge continuity gap in neurological rehabilitation through its CE-certified myReha mobile therapy app, which delivers personalized speech, language, cognitive, and motor exercises and is integrated into clinical workflows via the nyra insights web platform and the AI-driven nyra Content Studio tooling for therapists. The underlying technology stack combines Whisper-based automatic speech recognition, NLP pipelines for aphasia and dementia classification, MMSE score prediction, and multimodal AI models developed in collaboration with US universities. The company's US-market sub-brand is 'nyra therapy.'

nyra health operates a three-stream revenue model: B2C monthly and annual subscriptions for individual patients (preceded by a 7-day free trial), B2B licensing agreements with rehabilitation clinics and therapy practices, and insurance-covered sessions through partnerships with 28 health insurance providers across Germany, Austria, and Switzerland, including TK, AOK, Signal Iduna, and Barmenia. The platform is deployed in over 100 rehabilitation clinics (including Schmieder, SRH, Asklepios, and Mediclin) and has been used by 50,000+ patients across 65,000+ therapy tasks. nyra health maintains certifications including ISO 13485, ISO 27001/27017/27018, SOC 1-3, CE marking, and GDPR compliance.

The company has raised a total of approximately €24.5M, including a €4.5M seed round in 2023 and a €20M Series A in February 2026 led by Armira Growth with participation from Wellington Partners, Crane Venture Partners, and EVER Pharma. Use of proceeds is directed at DACH expansion, US market entry through the 'nyra therapy' sub-brand, and further development of multimodal AI capabilities, including a €4.2M research initiative with US universities. The company employs 11-50 people and is registered as nyra health GmbH in Vienna, Austria.

nyra health firmographics

Firmographics
Name
nyra health
Legal name
nyra health GmbH
Website
https://nyra.health
Company type
Private
Founded year
2018
Operating status
Operating
Headcount range
11–50 employees
Short description
nyra health is a Vienna-based HealthTech company building an AI-powered digital neurotherapy platform for stroke, dementia, Parkinson's, and brain injury patients, delivering personalized speech, cognitive, and motor therapy through its CE-certified myReha app and nyra insights clinical platform across the DACH region.
Ownership category
akta.pro rank

nyra health industry classification

Industry
Product category
Digital Neurorehabilitation Software
NAICS
Offices of Physical, Occupational and Speech Therapists, and Audiologists (62134), Offices of Physical, Occupational and Speech Therapists, and Audiologists (621340)
SIC
Services-Prepackaged Software (7372), Services-Home Health Care Services (8082), Services-Health Services (8000)
akta.pro primary industry
Behavioral Health & Neurocognitive Therapeutics (Digital) (HLACANAI)
akta.pro secondary industries
Remote Therapeutic Monitoring (RTM) & Digital Rehabilitation Platforms (HLALABAK), Digital Rehabilitation & Physical Therapy Therapeutics (HLACANAJ), Cognitive-Communication & Memory Rehab Therapy In-Home (HSABADAL)

Keywords

  • Digital neurotherapy
  • AI neurorehabilitation
  • Speech therapy software
  • Cognitive rehabilitation platform
  • Telemedicine stroke recovery

Where nyra health is headquartered

Location

Headquarters

HQ city
Vienna
HQ country
Austria
HQ region
Europe

Offices1 record

Markets served

nyra health business model

Business model
GTM type
B2B and B2C
Offering type
Software
Cost components
Personnel, Technology or R&D, Operations, Marketing or Sales, Infrastructure

Revenue model

  1. Patient Subscriptions (B2C): Monthly and annual subscription plans for patients accessing the digital neurotherapy platform. Premium tiers offer enhanced features and extended therapy programs. A 7-day free trial enables user acquisition before conversion to paid subscriptions.
  2. Clinic/Healthcare Provider Licensing: B2B licensing agreements with rehabilitation clinics, therapy practices, and healthcare systems for institutional access to the nyra health platform. Clinics license the platform for use with their patient populations.
  3. Insurance Reimbursement Partnerships: Partnerships with health insurance companies enable coverage of nyra health therapy programs for insured members, creating a reimbursement pathway similar to traditional therapy sessions.

Pricing tiers

ModelBillingPrice
SubscriptionMonthlyStandard Monthly Subscription
SubscriptionAnnualPremium Annual Subscription
Usage-basedPay-as-you-goInsurance-Covered Sessions

Go-to-market motion2 records

Distribution channels4 records

Marketing channels5 records

nyra health product offering

Product offering

Core offering

nyra health sells a modular AI-powered digital neurotherapy ecosystem consisting of the myReha CE-certified mobile therapy app (speech, language, and cognitive rehabilitation for stroke, dementia, Parkinson's, TBI, and MS patients), the nyra insights web platform for clinician patient management and telemedical monitoring, and the nyra Content Studio AI tool for therapists to generate personalized therapy materials. The platform supports care from inpatient clinics to at-home therapy and is distributed through app stores, clinic licensing, and insurance reimbursement across the DACH region with US expansion underway.

Product overview

nyra health offers a modular digital neurotherapy ecosystem consisting of three interconnected products: myReha (core mobile therapy app for patients), nyra insights (web-based clinical management platform), and nyra Content Studio (AI-powered content generation tool). The system provides seamless care from clinic to home, covering speech therapy, cognitive rehabilitation, and occupational therapy through over 65,000 interactive tasks. The platform operates across Germany, Austria, and Switzerland with reimbursement agreements covering 40 million insured individuals, while nyra therapy serves as the US-market sub-brand for the company's neurorehabilitation solutions.

Differentiator

Problem solved

Functional benefit

Brands

  • myReha: AI-powered therapy app for neurological disorders covering speech, language, and cognitive therapy. CE-certified medical device deployed in rehabilitation clinics.
  • nyra insights
  • nyra Content Studio

Products and services

  • myReha CE-certified AI-powered mobile therapy application for smartphone and tablet providing personalized speech, language, and cognitive rehabilitation exercises for patients with neurological conditions including stroke, dementia, Parkinson's, traumatic brain injury, Long COVID, and multiple sclerosis. Targets individual patients for at-home therapy and is also deployed in clinical settings.
  • nyra insights Web-based therapy platform for healthcare professionals enabling telemedical care, therapy documentation, patient management, and real-time monitoring of patient progress across clinics and practices. Targets clinicians and therapy teams as the institutional counterpart to the myReha patient app.
  • nyra Content Studio AI-powered therapy content creation tool enabling therapists to generate personalized therapy materials in seconds using conversational AI. Designed for speech therapy, occupational therapy, and neuropsychology practices.
  • nyra therapy US-market sub-brand of nyra health's neuro-rehabilitation platform enabling transition from inpatient care to home-based therapy, covering stroke, dementia, Parkinson's disease, Long COVID, traumatic brain injury, and multiple sclerosis for American patients and providers.

Quantifiable outcome

  • 50,000+ patients have used the platform for neurological rehabilitation
  • +3 more outcomes

Companies that use nyra health

Customer profile

Named customers4 records

Segments3 records

Ideal customer profiles3 records

nyra health technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

AI capability8 records

Feature3 records

nyra health partnerships and signals

Strategic signal

Scale indicators5 records

Recent moves6 records

Expansion highlights5 records

nyra health competitors and assessment

Company assessment

Market position

Competitive moat5 records

Key risks6 records

Key highlights6 records

Customer concentration

nyra health social profiles

Digital presence

nyra health compliance and trust

Trust signal

Compliance9 records

nyra health financial estimates

Financial estimate

Revenue estimate

Valuation estimate

nyra health leadership team

Management profile

Number of profiles

Profiles3 records

nyra health funding detail

Funding detail

Funding overview

Funding rounds3 records

Investors6 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

nyra health M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about nyra health

What does nyra health do?

nyra health sells a modular AI-powered digital neurotherapy ecosystem consisting of the myReha CE-certified mobile therapy app (speech, language, and cognitive rehabilitation for stroke, dementia, Parkinson's, TBI, and MS patients), the nyra insights web platform for clinician patient management and telemedical monitoring, and the nyra Content Studio AI tool for therapists to generate personalized therapy materials. The platform supports care from inpatient clinics to at-home therapy and is distributed through app stores, clinic licensing, and insurance reimbursement across the DACH region with US expansion underway.

Is nyra health a public or private company?

nyra health is a private company. It is classified as venture growth investor backed and is currently operating.

When was nyra health founded?

nyra health was founded in 2018. It employs 11 to 50 people.

Where is nyra health based?

nyra health is headquartered in Vienna, Austria, in the Europe region.

How does nyra health make money?

Three revenue lines are on record. Patient Subscriptions (B2C) is the primary driver. The others are clinic/Healthcare Provider Licensing and insurance Reimbursement Partnerships.

Does nyra health have an API?

No public API is recorded for nyra health.

What industry is nyra health in?

nyra health's product category is Digital Neurorehabilitation Software. Its primary akta.pro industry code is HLACANAI, Behavioral Health & Neurocognitive Therapeutics (Digital), with a secondary code of HLALABAK, Remote Therapeutic Monitoring (RTM) & Digital Rehabilitation Platforms. Its NAICS code is 62134 and its SIC code is 7372.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
Startupmafianyra health Raises €20M to Scale AI Neurotherapy Amid €65B Neurological Care GapVienna-based HealthTech startup nyra health has closed a €20 million Series A round led by Armira Growth, with participation from Wellington Partners, Crane Venture Partners, and EVER Pharma, to expand its AI-powered neurorehabilitation platform across the DACH region and enter the US market. The funding addresses a €65 billion neurological care gap in Germany alone, where the company already operates in over 100 rehabilitation clinics and has reimbursement agreements with 28 health insurance providers covering 40 million insured individuals. nyra health is simultaneously developing multimodal AI systems in partnership with US universities through a €4.2 million research initiative.EU-StartupsAmid €65 billion lost each year to stroke and dementia in Germany, nyra health secures €20 million to scale digital neurotherapyVienna-based nyra health has completed a €20 million Series A funding round led by Armira Growth, with participation from Wellington Partners, Crane Venture Partners, and EVER Pharma, to expand its AI-based neurorehabilitation platform in the DACH region and enter the US market. The company's MDR Class IIa certified product myReha is already deployed in over 100 rehabilitation clinics and integrated with the German Pension Insurance Fund's aftercare programme, providing 28 health insurance companies and more than 40 million insured individuals access to AI-supported speech, cognitive, and motor skills therapy. The funding comes as neurological diseases cost Germany approximately €65 billion annually due to care gaps after hospital discharge, and nyra health will use €4.2 million of the proceeds for a funded research project with US universities to develop multimodal AI models for therapeutic interaction and diagnostics.VestbeeVienna neuro-AI startup nyra health raises €20M Series A to scale digital neurotherapy platformVienna-based neuro-AI startup nyra health has secured a €20 million Series A financing round led by Armira Growth, with participation from Wellington Partners, Crane Venture Partners, and EVER Pharma. The company, founded in 2018, develops the AI-driven myReha platform for neurological rehabilitation covering speech, cognition, and motor therapy, which is currently implemented in over 100 rehabilitation clinics and reimbursed by 28 health insurers covering roughly 40 million insured individuals. nyra health plans to use the funding to expand across the DACH region and enter the US market while enhancing its multimodal AI models and clinical features.Pulse 2.0Nyra Health: €20 Million Series A Raised For AI-Based Neurotherapy Platform ExpansionVienna-based digital health company Nyra Health has raised €20 million in Series A funding, led by Armira Growth with participation from Wellington Partners, Crane Venture Partners, and EVER Pharma. The capital will fund international expansion of its AI-powered neurotherapy platform myReha, scaling across the DACH region and preparing for U.S. market entry. The platform, used in over 100 neurological clinics and integrated into Germany's largest rehabilitation provider's standard care, addresses a €65 billion annual neurological disease cost burden in Germany due to insufficient follow-up care.Startbase20 million euros for AI-supported neurotherapy goes to nyra healthViennese HealthTech nyra health has closed a Series A financing round of 20 million euros, led by Armira Growth with participation from existing investors Wellington Partners, Crane Venture Partners, and EVER Pharma. The capital will fund international expansion, further development of its AI-powered "myReha" neurotherapy platform, and preparation for US market entry. The platform is already MDR IIa-certified, deployed in over 100 clinics, and covered by 28 statutory and private health insurance companies, reaching approximately 40 million insured persons in Germany, Austria, and Switzerland.LinkedIn#nyrahealth #neurotherapy #neurorehabilitation #aiinhealthcare #healthtech #digitalhealth #innovationVienna-based nyra health secured €20 million in a Series A funding round to expand its AI-driven neurotherapy platform across the DACH region and the US. The platform is already integrated into over 100 clinics and aims to improve treatment accessibility for neurological diseases.